Proteasome Regulation of Interleukin-5 Receptor Endocyt*

Interleukin-5 受体内吞细胞的蛋白酶体调节*

基本信息

项目摘要

DESCRIPTION (provided by applicant): Interleukin-5 (IL-5) is a hematopoietic cytokine that is central to the pathophysiology of eosinophilic inflammation in atopy and asthma. Understanding mechanisms that extinguish IL-5 receptor (IL-5R)-induced inflammatory signals has importance for the development of novel approaches to modulate IL-5-mediated inflammation. The goal of this application is to define the molecular mechanisms controlling IL-5R internalization by the ubiquitin and proteasome degradation pathway. Our overall hypothesis is that IL-5-induced IL-5R internalization is regulated by two different mechanisms: the ubiquitin/proteasome degradation pathway and clathrin-mediated endocytosis. Aim 1. Test the hypothesis that proteasomes mediate internalization of the ligated IL-5R by first degrading the (c cytoplasmic domain. To determine if degradation of a portion of the (c cytoplasmic domain is the initiating signal for IL-5R internalization, various cytoplasmically truncated (c mutants will be examined for their ability to mediate proteasome-independent internalization of the ligated IL-5R. In addition, requirement for proteasome activity in (c internalization by the other (c engaging cytokines, IL-3 and GM-CSF, will be investigated. Aim 2. Test the hypothesis that the IL-5R is internalized by clathrin-mediated endocytosis and that internalization of the receptor occurs before proteasome degradation of the (c cytoplasmic domain. Two different approaches that inhibit clathrin-mediated endocytosis will be used to determine if the IL-5R is internalized by this mechanism and if IL-5-stimulated (c signaling and proteasome degradation occur after IL-5R internalization. Aim 3. Investigate the functional role and nature of (c ubiquitination in IL-5R internalization. The temperature sensitive ts20 cell line which has a temperature sensitive defect in ubiquitin conjugation, a (c mutant that is defective in all forms of ubiquitination, and dominant negative ubiquitin isoforms will be used to examine the role and nature of (c ubiquitination in IL-5R endocytosis.
描述(由申请人提供):白细胞介素-5(IL-5)是一种造血细胞因子,在特应性和哮喘中嗜酸性粒细胞炎症的病理生理学中起着重要作用。了解消除IL-5受体(IL-5 R)诱导的炎症信号的机制对于开发新的方法来调节IL-5介导的炎症具有重要意义。本申请的目的是确定通过泛素和蛋白酶体降解途径控制IL-5 R内化的分子机制。我们的总体假设是,IL-5诱导的IL-5 R内化是由两种不同的机制:泛素/蛋白酶体降解途径和网格蛋白介导的内吞作用。目标1。检验蛋白酶体通过首先降解胞质结构域介导连接的IL-5 R内化的假设。为了确定β胞质结构域的一部分的降解是否是IL-5 R内化的起始信号,将检查各种胞质截短的β突变体介导连接的IL-5 R的蛋白酶体非依赖性内化的能力。此外,还将研究其他α-接合细胞因子IL-3和GM-CSF在α-内化中对蛋白酶体活性的要求。目标2.检验以下假设:IL-5 R通过网格蛋白介导的内吞作用内化,并且受体的内化发生在β胞质结构域的蛋白酶体降解之前。将使用抑制网格蛋白介导的内吞作用的两种不同方法来确定IL-5 R是否通过该机制内化,以及IL-5刺激的β信号传导和蛋白酶体降解是否在IL-5 R内化后发生。目标3.研究β-泛素化在IL-5 R内化中的功能作用和性质。温度敏感性ts 20细胞系在泛素缀合中具有温度敏感性缺陷,是在所有形式的泛素化中都有缺陷的β突变体,并且显性负性泛素同种型将用于检查β泛素化在IL-5 R内吞作用中的作用和性质。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAGARITA MARTINEZ-MOCZYGEMBA其他文献

MAGARITA MARTINEZ-MOCZYGEMBA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAGARITA MARTINEZ-MOCZYGEMBA', 18)}}的其他基金

Proteasome Regulation of Interleukin-5 Receptor Endocyt*
Interleukin-5 受体内吞细胞的蛋白酶体调节*
  • 批准号:
    6948288
  • 财政年份:
    2004
  • 资助金额:
    $ 32.96万
  • 项目类别:
Proteasome Regulation of Interleukin-5 Receptor Endocytosis
Interleukin-5 受体胞吞作用的蛋白酶体调节
  • 批准号:
    7195020
  • 财政年份:
    2004
  • 资助金额:
    $ 32.96万
  • 项目类别:
Proteasome Regulation of Interleukin-5 Receptor Endocytosis
Interleukin-5 受体胞吞作用的蛋白酶体调节
  • 批准号:
    7731884
  • 财政年份:
    2004
  • 资助金额:
    $ 32.96万
  • 项目类别:
Proteasome Regulation of IL-5 Receptor Endocytosis
IL-5 受体胞吞作用的蛋白酶体调节
  • 批准号:
    6861635
  • 财政年份:
    2004
  • 资助金额:
    $ 32.96万
  • 项目类别:
Regulation of Interleukin-5 Receptor Signaling
IL-5 受体信号传导的调节
  • 批准号:
    6416767
  • 财政年份:
    2002
  • 资助金额:
    $ 32.96万
  • 项目类别:
Regulation of Interleukin-5 Receptor Signaling
IL-5 受体信号传导的调节
  • 批准号:
    6650360
  • 财政年份:
    2002
  • 资助金额:
    $ 32.96万
  • 项目类别:

相似海外基金

Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
  • 批准号:
    23K06731
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
  • 批准号:
    23K06616
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
  • 批准号:
    10597799
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
  • 批准号:
    EP/Y024591/1
  • 财政年份:
    2023
  • 资助金额:
    $ 32.96万
  • 项目类别:
    Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
  • 批准号:
    10672364
  • 财政年份:
    2022
  • 资助金额:
    $ 32.96万
  • 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
  • 批准号:
    10385037
  • 财政年份:
    2022
  • 资助金额:
    $ 32.96万
  • 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
  • 批准号:
    10383462
  • 财政年份:
    2022
  • 资助金额:
    $ 32.96万
  • 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
  • 批准号:
    10483063
  • 财政年份:
    2022
  • 资助金额:
    $ 32.96万
  • 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
  • 批准号:
    2752732
  • 财政年份:
    2022
  • 资助金额:
    $ 32.96万
  • 项目类别:
    Studentship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
  • 批准号:
    10546865
  • 财政年份:
    2022
  • 资助金额:
    $ 32.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了